RIM
ABBV icon

Reynolds Investment Management’s AbbVie ABBV Stock Holding History

Reynolds Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$412K Sell
2,689
-50
-2% -$7.64K 0.15% 83
2022
Q1 		$444K Buy
+2,739
New +$398K 0.13% 84

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Reynolds Investment Management's ABBV Position: Q2 2022 in Review

Reynolds Investment Management reduced its AbbVie (ABBV) stake by 1.8% in Q2 2022, selling an estimated $7.64K and leaving 2,689 shares worth $412K. The position accounts for 0.15% of the portfolio, ranked #83.

Reynolds Investment Management first reported a position in ABBV in Q1 2022 and has held it in 2 quarters since. The position peaked at $444K in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Reynolds Investment Management held 2,689 shares of AbbVie worth $412K as of Q2 2022.
  • Reynolds Investment Management sold 50 AbbVie shares in Q2 2022, an estimated $7.64K.
  • AbbVie made up 0.15% of Reynolds Investment Management's portfolio in Q2 2022, its #83 holding.
  • Reynolds Investment Management first reported a position in AbbVie in Q1 2022 and has held it in 2 quarters since.
  • Reynolds Investment Management's AbbVie position peaked at $444K in Q1 2022.
  • 3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Reynolds Investment Management's 13F filing for Q2 2022, filed 27 Jul 2022.